CLPT - Company ID 0001285550
The table below shows ClearPoint Neuro, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q3 2026 | Q2 2026 | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Revenue | $12.07M | $10.88M | $12.13M | $8.86M | $9.21M | $8.48M |
| Cost of revenue | $5.02M | $4.17M | $4.37M | $3.26M | $3.66M | $3.35M |
| Gross profit | $7.06M | $6.71M | $7.76M | $5.60M | $5.56M | $5.13M |
| R&D | $4.02M | $4.63M | $4.52M | $3.45M | $3.83M | $3.38M |
ClearPoint Neuro, Inc. reported annual revenue of $36.97M for fiscal year 2025. That is up 17.8% from $31.39M in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $5.75M (FY 2016) to $36.97M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A | $3.84M | $5.55M | $5.00M | $3.59M | $3.39M | $4.08M |
| Operating income | -$6.33M | -$10.24M | -$8.48M | -$5.28M | -$5.68M | -$6.16M |
| Income tax | -$4.00K | -$38.00K | $8.00K | $8.00K | $25.00K | $18.00K |
| Net income | -$7.46M | -$11.34M | -$9.55M | -$5.89M | -$5.84M | -$6.03M |
| EPS (diluted) | -$0.24 | -$0.38 | -$0.32 | -$0.21 | -$0.21 | -$0.22 |